BSPK Stock Overview
Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bespoke Extracts, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.061 |
| 52 Week High | US$1.00 |
| 52 Week Low | US$0.019 |
| Beta | 0.94 |
| 1 Month Change | -59.60% |
| 3 Month Change | -13.30% |
| 1 Year Change | -13.55% |
| 3 Year Change | -95.03% |
| 5 Year Change | -97.74% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BSPK | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -31.3% | -2.2% | -3.7% |
| 1Y | -13.6% | 11.6% | 20.5% |
Return vs Industry: BSPK underperformed the US Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: BSPK underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| BSPK volatility | |
|---|---|
| BSPK Average Weekly Movement | 42.5% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BSPK's share price has been volatile over the past 3 months.
Volatility Over Time: BSPK's weekly volatility has decreased from 66% to 42% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Michael Feinsod | bespokeextracts.com |
Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products. The company offers CBD formulations, including manuka honey and in the form of lotions and balms. It offers its products through its direct to consumers e-commerce store bespokeextracts.com.
Bespoke Extracts, Inc. Fundamentals Summary
| BSPK fundamental statistics | |
|---|---|
| Market cap | US$766.17k |
| Earnings (TTM) | -US$2.21m |
| Revenue (TTM) | US$521.67k |
1.2x
P/S Ratio-0.3x
P/E RatioIs BSPK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSPK income statement (TTM) | |
|---|---|
| Revenue | US$521.67k |
| Cost of Revenue | US$295.45k |
| Gross Profit | US$226.22k |
| Other Expenses | US$2.44m |
| Earnings | -US$2.21m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 43.37% |
| Net Profit Margin | -423.90% |
| Debt/Equity Ratio | -56.6% |
How did BSPK perform over the long term?
See historical performance and comparison